Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by F.F. Hamers
Exploring Uncertainty in Economic Evaluation of Medicines: A Review of the First Manufacturers' Submissions to the French National Authority for Health (Has)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Use of Budget Impact Analysis (Bia) in Economic Evaluations of Drugs and Medical Devices Submitted to the French National Authority for Health (Has)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Methodological Analyses of Budget Impact Models Submitted to the Haute Autorité De Santé (HAS) (French National Authority for Health)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exploration of the Difference in Results of Economic Submissions to the National Institute of Clinical Excellence by Manufacturers and Assessment Groups
International Journal of Technology Assessment in Health Care
Health Policy
Prm67 - Utilities in Oncology Submissions Submitted to Nice —Approach of the Manufacturers
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
From Foreign to National: A Review of the Status of the French Language in Gabon
Literator
Linguistics
Literature
Literary Theory
Language
PIH26 Economic Evaluation of Dienogest for Endometriosis in the Context of Korea National Health Insurance
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
National Medicines Policies – A Review of the Evolution and Development Processes
Journal of Pharmaceutical Policy and Practice
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Analysis of Assortiment of Medicines for the Treatment of Benign Prostate Diseases for the Evaluation of Particular Marketing Opportunities for Domestic Manufacturers
ScienceRise: Pharmaceutical Science
